More Videos
|
CNBC'S MOST SHARED
- Market 360: The Week's Best & Worst
- Fireworks At Pharma's Market
- Value of Warren Buffett's Annual Gift to Gates Foundation Falls Along With Berkshire's Stock
- Michael Jackson: The Music And The Money
- Five Stock Picks for This Market
- Realities of the New Obama Refis
- Weak Dollar Means Gold at $1,040: Strategist
- Court Ruling Could Mean Trouble for TiVo
- Lance, Please Back Out Of Tour
- UBS Says It Stays Committed to US Brokerage
- Plan to Sell General Motors' Assets Is Approved
- China Launches Major Step to Yuan Internationalization
- China Says 140 Die in Rioting
- Obama's Russia Visit to Bring Over $1.5 Billion in Deals
- UK Spy Chief's Wife Posts Life on Facebook
- BOJ Shirakawa: Japan Corporate Finance Still Tight
- Alcoa to Post Loss — What Does This Mean?
- A Goldman Trading Scandal?
RSS FEED
Text Size 
 |
CNBC.com |
] management at the start of the Q and A portion of the biotech company's analyst meeting? Yep. Mark Schoenebaum from Bear Stearns [BSC
Loading...
()
]. When they get the mike, the analysts all state their names and the firms they work for. And as soon as Schoenebaum said, "Bear Stearns", Genentech CEO Art Levinson yells out, "You mean there's somebody from Bear Stearns still here?" The room erupted in laughter.
Schoenebaum came back with a quick retort, "You guys (the Genentech team) do great work," jokingly hinting he might need to butter them up for a job soon. Genentech's CFO, David Ebersman, used to be a sell-side analyst. By the way, I'll be doing a "First On CNBC" interview with Ebersman on "Closing Bell" at 3 p.m. ET today.
And then toward the end of the Q and A session an analyst gets the mike and once again prefaces his question by introducing himself, "Geoffrey Meacham with JPMorgan...soon to be the parent company, I guess, of Bear Stearns."
Laughter ensues. The meeting ends.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes